JNJ Johnson & Johnson

NYSE
$260.35

Johnson & Johnson (JNJ) is expected to report earnings on October 19, 2026, before the market open. The consensus earnings estimate is $2.95 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +4.1% since its last earnings release on July 15, 2026.

Johnson & Johnson Beat Expectations, Raises Guidance
Wednesday, July 15, 2026 · 6:20 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 19
Monday · 6:20 AM ET
Earnings Whisper
-
vs $2.95
Rev est $25.34B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $257.19

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices, and Diagnostics business segments.

Sector

Healthcare

Industry

Drug Manufacturers / Major